Close Menu

StemCells plans to acquire certain assets of UK-based Stem Cell Sciences for as much as $4.85 million, the companies said this week.

As part of the deal, Palo Alto, Calif.-based StemCells plans to provide SCS with 2.65 million of its shares and approximately $715,000 in waived loan payments.

Expected to close within two months, the deal will see StemCells acquire SCS' R&D operations in Cambridge, UK, and a facility near Melbourne, Australia.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

A Harvard University professor has been charged with making false claims regarding funds he received from China, the New York Times reports.

Discover magazine reports that animal dissections might dissuade students from science careers, but that a firm has developed synthetic frogs for dissections.

Nature News reports that a US panel is reviewing current guidelines for federally funded gain-of-function viral research.

In PNAS this week: de novo mutation patterns among the Amish, an alternative RNA-seq method, and more.